The Role of Tumor Cell–Derived Connective Tissue Growth Factor (CTGF/CCN2) in Pancreatic Tumor Growth
- 29 January 2009
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 69 (3), 775-784
- https://doi.org/10.1158/0008-5472.can-08-0987
Abstract
Pancreatic cancer is highly aggressive and refractory to existing therapies. Connective tissue growth factor (CTGF/CCN2) is a fibrosis-related gene that is thought to play a role in pancreatic tumor progression. However, CCN2 can be expressed in a variety of cell types, and the contribution of CCN2 derived from either tumor cells or stromal cells as it affects the growth of pancreatic tumors is unknown. Using genetic inhibition of CCN2, we have discovered that CCN2 derived from tumor cells is a critical regulator of pancreatic tumor growth. Pancreatic tumor cells derived from CCN2 shRNA–expressing clones showed dramatically reduced growth in soft agar and when implanted s.c. We also observed a role for CCN2 in the growth of pancreatic tumors implanted orthotopically, with tumor volume measurements obtained by positron emission tomography imaging. Mechanistically, CCN2 protects cells from hypoxia-mediated apoptosis, providing an in vivo selection for tumor cells that express high levels of CCN2. We found that CCN2 expression and secretion was increased in hypoxic pancreatic tumor cells in vitro, and we observed colocalization of CCN2 and hypoxia in pancreatic tumor xenografts and clinical pancreatic adenocarcinomas. Furthermore, we found increased CCN2 staining in clinical pancreatic tumor tissue relative to stromal cells surrounding the tumor, supporting our assertion that tumor cell–derived CCN2 is important for pancreatic tumor growth. Taken together, these data improve our understanding of the mechanisms responsible for pancreatic tumor growth and progression, and also indicate that CCN2 produced by tumor cells represents a viable therapeutic target for the treatment of pancreatic cancer. [Cancer Res 2009;69(3):775–84]This publication has 52 references indexed in Scilit:
- Hypoxia in Human Trophoblasts Stimulates the Expression and Secretion of Connective Tissue Growth FactorEndocrinology, 2008
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- Cyr61/CCN1 and CTGF/CCN2 mediate the proangiogenic activity of VHL -mutant renal carcinoma cellsCarcinogenesis: Integrative Cancer Research, 2008
- Pancreatic cancer–associated stroma productionThe American Journal of Surgery, 2007
- Analysis of CCN2 promoter activity in PANC-1 cells: regulation by ras/MEK/ERKJournal of Cell Communication and Signaling, 2007
- Expression of Cyr61, CTGF, and WISP-1 Correlates with Clinical Features of Lung CancerPLOS ONE, 2007
- Connective tissue growth factor (CTGF) expression and outcome in adult patients with acute lymphoblastic leukemiaBlood, 2006
- Hypoxia induces expression of connective tissue growth factor in scleroderma skin fibroblastsClinical and Experimental Immunology, 2006
- Genome‐wide gene expression profiling of cervical cancer in Hong Kong women by oligonucleotide microarrayInternational Journal of Cancer, 2006
- Insights Into the Molecular Mechanism of Chronic Fibrosis: The Role of Connective Tissue Growth Factor in SclerodermaJournal of Investigative Dermatology, 2004